SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-003946
Filing Date
2017-08-14
Accepted
2017-08-14 16:47:17
Documents
49
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctxr_10q.htm 10-Q 456708
2 CERTIFICATION ctxr_ex311.htm EX-31.1 8905
3 CERTIFICATION ctxr_ex321.htm EX-32.1 3302
  Complete submission text file 0001477932-17-003946.txt   2928155

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctxr-20170630.xml EX-101.INS 412817
5 XBRL TAXONOMY EXTENSION SCHEMA ctxr-20170630.xsd EX-101.SCH 49655
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctxr-20170630_cal.xml EX-101.CAL 41107
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctxr-20170630_def.xml EX-101.DEF 150852
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctxr-20170630_lab.xml EX-101.LAB 258683
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctxr-20170630_pre.xml EX-101.PRE 221795
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 171031034
SIC: 2834 Pharmaceutical Preparations